SCHEMBL7426409

SCHEMBL7426409

Cc1cc(C#Cc2ccc(-c3ccccc3)cc2)nc(C)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 9/20 0.55
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
THPO P40225 1/20 0.47
KMT2A Q03164 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRM1 Q13255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7389576 0.78 GRM5 (0.67) GRM5NPC1RAB9ASMN1; SMN2CYP1A2
Hydrochloric Acid SCHEMBL7418874 0.77 GRM5 (0.65) GRM5NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL15014176 0.70 CYP1A1 (0.64) GRM5NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL10060646 0.70 L3MBTL1 (0.61) GRM5NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL5886608 0.70 APP (0.71) GRM5NPC1SMN1; SMN2CYP1A2KDM4E
SCHEMBL13377842 0.69 GRM5 (0.57) GRM5NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL27430949 0.68 ADORA2A (0.52) NPC1RAB9ASMN1; SMN2CYP1A2KDM4E
Methane SCHEMBL28739770 0.68 APP (0.67) GRM5NPC1SMN1; SMN2CYP1A2KDM4E
SCHEMBL14970094 0.67 TSHR (0.56) NPC1RAB9ASMN1; SMN2KDM4EMEN1
SCHEMBL5949303 0.67 APP (0.75) GRM5NPC1SMN1; SMN2CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed